Overview
Mika Sugiyama practices practicing medicine in Tokyo, Japan.
Their clinical expertise encompasses Dementia, COVID-19, Severe Acute Respiratory Syndrome (SARS), and Developmental Dysphasia Familial.
They are actively involved in clinical research, co-authoring 51 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mika Sugiyama
Is Mika Sugiyama a top-rated expert for Dementia?
MediFind is an objective health platform that identifies experts based on real-world data. Mika Sugiyama is classified as an Experienced expert for Dementia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mika Sugiyama participate in research or clinical trials?
Yes. Mika Sugiyama has published 51 articles and abstracts on conditions like Dementia. You can view a list of Mika Sugiyama's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- COVID-19Sugiyama isExperienced. Learn about COVID-19.
- DementiaSugiyama isExperienced. Learn about Dementia.
- Developmental Dysphasia FamilialSugiyama isExperienced. Learn about Developmental Dysphasia Familial.
- Severe Acute Respiratory Syndrome (SARS)